Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, side effects from a Mounjaro injection begin within a few hours to two days of the dose. The gastrointestinal effects — nausea especially — tend to peak in the first 48 hours and then ease off as the body adjusts. This pattern is consistent with what trial participants reported and with NHS guidance on tirzepatide. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial (which studied tirzepatide across 72 weeks in thousands of adults and was published in the New England Journal of Medicine) found that gastrointestinal side effects were most common during the early weeks of treatment and during dose increases, not as a sustained plateau. The NHS tirzepatide medicines page echoes this: nausea, vomiting, diarrhoea, constipation and indigestion are the most frequently reported effects, and they typically arise shortly after an injection rather than building gradually over days.
In practical terms, the window people most often notice is somewhere between two and 24 hours after injecting. Some feel mild queasiness the same evening; others notice it the morning after. The sharpest discomfort usually passes within two to five days at a given dose. That settling period is the reason the Mounjaro injection schedule is designed to hold each dose for around four weeks before any increase, your system gets time to adjust before the next step up.
If you want a closer look at how soon after injecting Mounjaro you can expect side effects to appear, that page walks through the typical onset window in more detail. That practical layer of self-management, alongside your prescriber's guidance, makes a real difference to how the early weeks feel.
There is a clear biological reason why the 2.5mg starting dose tends to produce more noticeable GI effects than later doses at the same level. Tirzepatide slows gastric emptying (the rate at which food leaves the stomach) and reduces appetite signals. Both effects are new to the body at the first injection. The gut is adapting to a mechanism it has not encountered before, which is why nausea, burping and loose stools tend to cluster in those first few days.
The same logic applies every time the dose increases. People who sail through the 2.5mg weeks sometimes find 5mg or 7.5mg brings a brief return of nausea. It is not a sign that something has gone wrong; it is the same adjustment process repeating at a higher level. As a rough guide, most people find any new dose-related discomfort settles within one to two weeks, though that varies person to person.
Other reported effects (headache, fatigue, dizziness) also tend to cluster around injection day and the day or two following it. Injection-site reactions, such as redness or mild swelling where the pen was used, can appear within hours and usually resolve quickly. Rotating between the abdomen, thigh and upper arm helps reduce site-specific irritation. You can read a fuller overview of the reported effects on our Mounjaro injection side effects page.
Most side effects from Mounjaro are mild to moderate and self-limiting. A few require prompt medical attention. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines flagged acute pancreatitis as a known but uncommon serious risk: the warning sign is severe stomach pain that does not ease and may radiate to the back, sometimes with vomiting. If that happens, stop injecting and go to A&E or call 999. Do not wait to see whether it settles.
Other symptoms that warrant contacting a doctor or 111 promptly include signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), symptoms of significant dehydration after prolonged vomiting or diarrhoea (very dark urine, dizziness on standing, inability to keep fluids down), and any sudden changes in vision. The MHRA Yellow Card scheme lets patients and carers report suspected side effects directly, those reports genuinely inform ongoing medicine safety monitoring.
If you are unsure whether a symptom needs attention, our prescribers are reachable through aftercare seven days a week. For non-urgent questions about what to expect, the FAQs cover many common queries, and the effects timeline page explains what people typically notice across the first few weeks.
Trial data and clinical experience both point in the same direction: pacing and consistency reduce the impact of early side effects. Eating smaller portions, avoiding very fatty or rich meals on injection day, and keeping the pen stored correctly (refrigerated at 2–8°C, some people keep theirs in the fridge door, which is fine as long as it stays within that range) all make a practical difference. Always check the Patient Information Leaflet for exact storage guidance.
Hydration matters more than many people expect. The GI effects of tirzepatide (particularly in the first weeks) can quietly reduce fluid intake. Sipping water steadily through the day, rather than drinking large amounts at once, is easier on a nausea-prone stomach. Protein-rich foods tend to be better tolerated than high-fat ones during the adjustment phase, and eating slowly reduces burping and reflux.
If you are wondering whether Mounjaro could be clinically appropriate for you, our prescribers discuss both suitability and what to expect from side effects during the consultation. You can check your eligibility and start a free consultation today. For context on how long after injection Mounjaro starts working, that page is worth reading alongside this one to build a fuller picture of what to expect in the early weeks.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.